These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 29302196)

  • 1. When good times go bad: managing 'legal high' complications in the emergency department.
    Caffrey CR; Lank PM
    Open Access Emerg Med; 2018; 10():9-23. PubMed ID: 29302196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging drugs of abuse.
    Nelson ME; Bryant SM; Aks SE
    Emerg Med Clin North Am; 2014 Feb; 32(1):1-28. PubMed ID: 24275167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Legal Highs, Lethal Lows.
    Shah B; Heaps T
    Acute Med; 2015; 14(4):188-92. PubMed ID: 26726791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Legal highs" - new players in the old drama.
    Zawilska JB
    Curr Drug Abuse Rev; 2011 Jun; 4(2):122-30. PubMed ID: 21711229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current "legal highs".
    Johnson LA; Johnson RL; Portier RB
    J Emerg Med; 2013 Jun; 44(6):1108-15. PubMed ID: 23528960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, 'legal highs')? Implications for law enforcement and penalties.
    Rychert M; Wilkins C
    Drug Test Anal; 2016 Aug; 8(8):768-78. PubMed ID: 26857892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Legal Highs"--An Emerging Epidemic of Novel Psychoactive Substances.
    Zawilska JB
    Int Rev Neurobiol; 2015; 120():273-300. PubMed ID: 26070762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness.
    Gray R; Bressington D; Hughes E; Ivanecka A
    J Psychiatr Ment Health Nurs; 2016 Jun; 23(5):267-81. PubMed ID: 27037639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Legal highs"--toxicity in the clinical and medico-legal aspect as exemplified by suicide with bk-MBDB administration.
    Rojek S; Kłys M; Strona M; Maciów M; Kula K
    Forensic Sci Int; 2012 Oct; 222(1-3):e1-6. PubMed ID: 22648055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Designer drugs': update on the management of novel psychoactive substance misuse in the acute care setting.
    Smith CD; Robert S
    Clin Med (Lond); 2014 Aug; 14(4):409-15. PubMed ID: 25099844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment.
    Specka M; Kuhlmann T; Sawazki J; Bonnet U; Steinert R; Cybulska-Rycicki M; Eich H; Zeiske B; Niedersteberg A; Schaaf L; Scherbaum N
    Front Psychiatry; 2020; 11():569. PubMed ID: 32733288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of legal high materials by ultra-performance liquid chromatography with time of flight mass spectrometry as part of a toxicology vigilance system: what are the most popular novel psychoactive substances in the UK?
    Ford LT; Berg JD
    Ann Clin Biochem; 2017 Mar; 54(2):219-229. PubMed ID: 27166311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of psychoactive and intoxicating substances in legal highs.
    Żukiewicz-Sobczak W; Zwoliński J; Chmielewska-Badora J; Krasowska E; Piątek J; Sobczak P; Wojtyła A; Fornal E; Kuczumow A; Biliński P
    Ann Agric Environ Med; 2012; 19(2):309-14. PubMed ID: 22742807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Ivory wave' toxicity in recreational drug users; integration of clinical and poisons information services to manage legal high poisoning.
    Murray DB; Potts S; Haxton C; Jackson G; Sandilands EA; Ramsey J; Puchnarewicz M; Holt DW; Johnston A; Nicholas Bateman D; Dear JW
    Clin Toxicol (Phila); 2012 Feb; 50(2):108-13. PubMed ID: 22224933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective observational study of emergency department presentations following novel psychoactive substance use.
    Henshall DE; Innes CW; Morrison SR; Wilson B; Brown RA; McAllister SM; Culshaw SL; Reda E
    Scott Med J; 2018 May; 63(2):39-44. PubMed ID: 29514583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Legal highs toxicity--symptomatology and clinical diagnosis in case series.
    Łukasik-Głebock M; Sommerfeld K; Nawrocka K
    Przegl Lek; 2010; 67(8):613-6. PubMed ID: 21384787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.
    Liechti M
    Swiss Med Wkly; 2015; 145():w14043. PubMed ID: 25588018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legal high industry business and lobbying strategies under a legal market for new psychoactive substances (NPS, 'legal highs') in New Zealand.
    Rychert M; Wilkins C
    Int J Drug Policy; 2016 Nov; 37():90-97. PubMed ID: 27639994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs of abuse: the highs and lows of altered mental states in the emergency department.
    Meehan TJ; Bryant SM; Aks SE
    Emerg Med Clin North Am; 2010 Aug; 28(3):663-82. PubMed ID: 20709248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designers Drugs-A New Challenge to Emergency Departments-An Observational Study in Poland.
    Jalali R; Dmochowska P; Godlewska I; Balmas J; Młynarska K; Narkun K; Zawadzki A; Wojnar M
    Medicina (Kaunas); 2020 Jul; 56(7):. PubMed ID: 32708850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.